That means GLP-1 receptor agonist users were more than twice as likely to develop allodynia compared to an active comparator group, not just compared to the general population
By improving cellular energy production, methylene blue could potentially lower that barrier to entry, making it easier to engage in and recover from physical activity
Understanding what USP 797 requires gives you insight into the quality controls behind your medication
Now she worries about being able to care for herself
The FDA notes that there are limitations to the data, including that while the database contains reports on a particular drug or biologic, this does not mean that the drug or biologic caused the adverse event meaning deaths may be unrelated to the drug
Contact your prescriber, GP, or midwife as soon as possible